These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Baseline features of idiopathic optic neuritis as determined by a multicenter treatment trial in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG). Wakakura M, Minei-Higa R, Oono S, Matsui Y, Tabuchi A, Kani K, Shikishima K, Kawai K, Nakao Y, Tazawa Y, Kiyosawa M, Abe H, Ohba N, Yago K, Maeda S, Sugita M, Ishikawa S. Jpn J Ophthalmol; 1999 Jun; 43(2):127-32. PubMed ID: 10340795 [Abstract] [Full Text] [Related]
7. [Short-term effect of megadose steroid therapy in optic neuritis]. Gerling J, Kommerell G. Klin Monbl Augenheilkd; 1992 Dec; 201(6):375-80. PubMed ID: 1287359 [Abstract] [Full Text] [Related]
8. Visual outcome after intravenous dexamethasone therapy for idiopathic optic neuritis in an Indian population: a clinical case series. Sethi HS, Menon V, Sharma P, Khokhar S, Tandon R. Indian J Ophthalmol; 2006 Sep; 54(3):177-83. PubMed ID: 16921215 [Abstract] [Full Text] [Related]
19. Contrast sensitivity and other vision tests in the optic neuritis treatment trial. Trobe JD, Beck RW, Moke PS, Cleary PA. Am J Ophthalmol; 1996 May 01; 121(5):547-53. PubMed ID: 8610798 [Abstract] [Full Text] [Related]
20. Outcomes of toll-like receptors' antagonism in steroid-resistant optic neuritis; a pilot study. Sudhalkar A, Khamar M, Khamar B. Graefes Arch Clin Exp Ophthalmol; 2012 Jun 01; 250(6):871-7. PubMed ID: 22169982 [Abstract] [Full Text] [Related] Page: [Next] [New Search]